CN1191839C - Medicine for treating pulmonery tuberculosis - Google Patents

Medicine for treating pulmonery tuberculosis Download PDF

Info

Publication number
CN1191839C
CN1191839C CNB001294326A CN00129432A CN1191839C CN 1191839 C CN1191839 C CN 1191839C CN B001294326 A CNB001294326 A CN B001294326A CN 00129432 A CN00129432 A CN 00129432A CN 1191839 C CN1191839 C CN 1191839C
Authority
CN
China
Prior art keywords
medicine
present
pulmonary tuberculosis
semen
functions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB001294326A
Other languages
Chinese (zh)
Other versions
CN1359691A (en
Inventor
黄英
姜明翔
晁振广
李景春
王建高
李晓梅
张宁东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Hongqi Pharmaceutical Co Ltd
Original Assignee
黄英
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 黄英 filed Critical 黄英
Priority to CNB001294326A priority Critical patent/CN1191839C/en
Publication of CN1359691A publication Critical patent/CN1359691A/en
Application granted granted Critical
Publication of CN1191839C publication Critical patent/CN1191839C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a medicine for treating pulmonary tuberculosis, which is prepared from medicines with the functions of resisting tubercle bacillus, moistening lungs to arrest cough, adjusting organism immunity and activating blood circulation to dissipate blood stasis, such as cochinchia momordica seeds, arisaema roots, vaccaria seeds, white pepper, glutinous rice, etc. The present invention is externally applied by matching a Yongquan acupoint, and thus, has the functions of resisting tubercle bacillus, relieving cough, reducing sputum, moistening lungs, activating blood circulation to dissipate blood stasis, regulating organism and improving immunity. The present invention can also treat bronchitis. The present invention has the characteristics of stable medical property, high curative effect, no need of mainline, no taking medicine, convenient use, no toxic or side effect, etc. The present invention provides a medicine for treating pulmonary tuberculosis with convenient use and good curative effect for patients.

Description

A kind of antimycobacterial drug
The present invention is a kind of phthisical medicine that is used for the treatment of, specifically a kind of with Chinese medicine be that raw material is made, be used for the treatment of phthisical medicine, and the using method of this medicine.
Pulmonary tuberculosis is a kind of common infectious disease, and morbidity back PD is fast, it is heavy to invade profit, and is fast by respiratory tract and aerial infection, is often threatening that people's is healthy.The phthisical measure of current treatment is a lot, also can control its infectious disease, but treat phthisical medicine at present, it all is the medicine that extracts by chemical method, these medicines injure patient's liver, kidney, stomach easily, as rifampicin medicine, to liver stimulate, to damage liver bigger, isoniazid damages and does not send nerve, and some other treatment tuberculosis medicine also easily stimulates, stomach.
The objective of the invention is to develop better motherland's natural plants Chinese medicine, exploitation traditional Chinese medicines resource, for society, prevent and cure diseases for the mankind, solve the existing problem and shortage part of current domestic and international treatment pulmonary tuberculosis medicine, a kind of have anti-mycobacterium tuberculosis, relieving cough and resolving phlegm, lung moistening, adjustment body are provided, improve immunity, be aided with the blood circulation promoting and blood stasis dispelling function, need not have an injection and to take orally, only cooperate the acupuncture point just can treat pulmonary tuberculosis, and the also double medicine of controlling the treating pulmonery tuberculosis of chronic bronchitis.
For realizing purpose of the present invention, the technical scheme of taking is: according to the traditional Chinese medical science pathological study and dialectical the executing of pulmonary tuberculosis are controlled principle, according to the Chinese prescription principle, by anti-mycobacterium tuberculosis, nourishing the lung to arrest cough, adjustment immunity of organisms, it is main being aided with the blood-activating stasis-removing kind medicine, cooperate outside the acupuncture point, reach treatment pulmonary tuberculosis, realization the present invention's purpose.
Pulmonary tuberculosis is called pulmonary tuberculosis in Chinese medicine, be pulmonary infection tubercule bacillus and the chronic expendable infectious disease that causes, clinical manifestation is a main symptom with cough, spitting of blood, hectic fever night sweat, belong to the precise and tiny hypofunction that chronic consumptive disease excessively causes the defeated water distribution paddy of transporting and transforming function of the spleen and stomach, can not biochemical QI and blood, lung lose moistening, do condition of disease power and descend, table Wei Bugu, tubercule bacillus is taken advantage of a weak point, due to the respiratory tract invasion lungs, lung tissue is damaged and morbidity.
The present invention is according to four above-mentioned big diseases, uses natural plants Chinese medicine, cooperate outside the acupuncture point, and the treatment pulmonary tuberculosis, and can doublely control bronchitis etc.
Medicine of the present invention by monarch, minister, help, make compatibility.Semen Momordicae, Semen Persicae, Semen Vaccariae, Rhizoma Arisaematis are monarch drug, Semen Momordicae is slightly poisonous, treating the poisonous disease with poisonous drugs, kill tubercule bacillus, Semen Persicae, Wang Shi stay row, Rhizoma Arisaematis blood circulation promoting and blood stasis dispelling, eliminate the phlegm, remove dry: Semen Armeniacae Amarum, Radix orixae japonicae belong to ministerial drug, have eliminating phlegm and stopping cough, anastalsis: Oryza glutinosa is assistant, messenger drug, belongs to the tying-in medicine.Therefore, medicament composing prescription of the present invention (by weight) is: 3~7 of Semen Momordicaes, 3~7 in Semen Persicae, Rhizoma Arisaematis 3~7 grams, Semen Vaccariae 3~7 grams, 3~7 in Semen Armeniacae Amarum, 3~7 of Radix orixae japonicaes, 3~7 in Oryza glutinosa.
Using method of the present invention:
With the common porphyrize powder of said medicine, transfer the Ao Yongquan acupuncture point, as can be made into the medicine adhesive plaster and be affixed on and gush the position, changed medicine one time in 12~16 hours, continuous 6~10 times, just can reach therapeutic effect, need not have an injection, also need not take Western medicine orally.
Gushing the warp that a spring cave belongs to kidney, be the well of kidney, is that arteries and veins gas goes out, and the function at this acupuncture point cooperates dirty dry, the pulmonary tuberculosis of curable substance according to the rule of " rushing down its son in fact " and " the dirty well of getting ", adjusts body, gets rid of toxin, suppresses tubercule bacillus, diminishes inflammation.Therefore, transfer medicine of the present invention on the Ao at the spring acupuncture point, continuous 6~10 times, just can reach the phthisical effect of treatment, be the medicine of ideal lungy due to dirty dry, the dirty consumptive disease of treatment.
Have only Semen Momordicae little slightly poisonous in the used medicine of the present invention, no big side effect, because medicine of the present invention is external, therefore, external is safe and reliable.
The present invention is safe and reliable through animal acute and chronic toxicity test proof, and the present invention uses through 268 routine lungers, and effective percentage reaches 98%.Because the present invention executes according to differential diagnosis in tcm to control principle and Chinese prescription principle, by anti-mycobacterium tuberculosis, nourishing the lung to arrest cough, adjust immunity of organisms, it is main being aided with the blood-activating stasis-removing kind medicine, cooperates external outside the spring acupuncture point, pharmaceutical purity platymiscium Chinese medicine, therefore, the present invention has anti-mycobacterium tuberculosis, relieving cough and resolving phlegm, lung moistening, blood circulation promoting and blood stasis dispelling, adjust body, improve the function of immunity, cooperate the spring acupuncture point, can treat pulmonary tuberculosis effectively, and can doublely control bronchitis, its efficacy stability, curative effect height, need not have an injection, need not take orally, easy to use, have no side effect, not impairing the liver, stomach, characteristics such as safe and reliable.For the treatment pulmonary tuberculosis provides a kind of esy to use, safe and reliable, novel antimycobacterial drug of having no side effect.

Claims (1)

1, a kind of antimycobacterial drug is characterized in that by its weight ratio being the medicament composing prescription of said antimycobacterial drug:
3~7 of Semen Momordicaes, 3~7 in Semen Persicae, Rhizoma Arisaematis 3~7 grams, Semen Vaccariae 3~7 grams, 3~7 in Semen Armeniacae Amarum, 3~7 of Radix orixae japonicaes, 3~7 in Oryza glutinosa.
CNB001294326A 2000-12-20 2000-12-20 Medicine for treating pulmonery tuberculosis Expired - Lifetime CN1191839C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001294326A CN1191839C (en) 2000-12-20 2000-12-20 Medicine for treating pulmonery tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001294326A CN1191839C (en) 2000-12-20 2000-12-20 Medicine for treating pulmonery tuberculosis

Publications (2)

Publication Number Publication Date
CN1359691A CN1359691A (en) 2002-07-24
CN1191839C true CN1191839C (en) 2005-03-09

Family

ID=4593502

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001294326A Expired - Lifetime CN1191839C (en) 2000-12-20 2000-12-20 Medicine for treating pulmonery tuberculosis

Country Status (1)

Country Link
CN (1) CN1191839C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008119255A1 (en) * 2007-03-30 2008-10-09 Shibing Chen Chinese medicinal compositions for treating tuberculosis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1320918C (en) * 2005-08-29 2007-06-13 焦仕 Miao medicine for treating tuberculosis and rheumatic heart disease and its compounding process and usage

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008119255A1 (en) * 2007-03-30 2008-10-09 Shibing Chen Chinese medicinal compositions for treating tuberculosis

Also Published As

Publication number Publication date
CN1359691A (en) 2002-07-24

Similar Documents

Publication Publication Date Title
CN1927160A (en) Gargle and its preparing process
CN1098317A (en) Health-care sachet and preparation method thereof
CN103719491B (en) A kind of sealwort invigorating the spleen moistening lung health protection tea and preparation method thereof
CN104932728A (en) Multifunctional computer mouse pad compounding activated carbon with anion minerals
CN1191839C (en) Medicine for treating pulmonery tuberculosis
CN105250385A (en) Nasal drops for treating infant nasal obstruction
CN1256926A (en) Pill for treating hemiplegia
CN1049591C (en) Infantile medicinal foot bandage, prescription and prodn. technology
CN107898989A (en) A kind of Chinese medicine composition for treating obstructive sleep apnea syndrome and preparation method thereof
CN103127473A (en) Pain-relieving paste
CN104915040A (en) Negative ion anti-sliding mouse wrist pad for computer with wrist massage function
CN105267376A (en) Sugongkangding pure Chinese herbal medicinal antibacterial agent
CN109646490A (en) A kind of nine sesame oil and preparation method thereof for preventing and treating allergic rhinitis
CN103638507A (en) Traditional Chinese medicine compound for treating headache
CN103202641A (en) Cervical adjustment treating medicine pillow
CN103536673B (en) Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof
CN102343081A (en) Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching
CN101695514B (en) Traditional Chinese medicinal preparation for treating trauma and cicatricial hyperplasia gargalesthesia and preparation method thereof
CN102068506A (en) Sterilizing and antimicrobial Chinese medicinal disinfectant
CN106729097A (en) A kind of Chinese medicine composition for treating wind-warm lung-heat
CN106420340A (en) Purple sand moxibustion chair
CN101612301A (en) Medicinal liquor for treating cough
CN105362774A (en) Traditional Chinese medicine preparation for treating rabies
CN105147828A (en) Traditional Chinese medicine for treating sleep apnea syndrome and preparation method thereof
CN107041912A (en) A kind of Chinese medicine for configuring simple treatment onychomycosis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SHENYANG HONGQI PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: HUANG YING

Effective date: 20091127

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20091127

Address after: Hunnan New District Shenyang city Liaoning province Luo Street No. 6

Patentee after: Shenyang Hongqi Pharmaceutical Co., Ltd.

Address before: Tai'an traffic hospital, No.1 Yi Sheng Road, Shandong, Tai'an

Patentee before: Huang Ying

CX01 Expiry of patent term

Granted publication date: 20050309

CX01 Expiry of patent term
DD01 Delivery of document by public notice

Addressee: Wang Zhuo

Document name: Notice of expiration of patent right

DD01 Delivery of document by public notice